ClinicalTrials.Veeva

Menu

Hidden Impairments During Subarachnoid Haemorrhage Recovery, Description and Evolution of a Newly Described Syndrom (HIDDEN)

A

Assistance Publique - Hôpitaux de Paris

Status

Not yet enrolling

Conditions

Intracranial Hemorrhages

Treatments

Other: IADL
Other: PCL-5
Other: SF-36
Other: mMRS
Other: SS-QoL
Diagnostic Test: MoCA
Other: Brief-Cope
Diagnostic Test: BREFF
Other: CIQ-R
Other: questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT06276517
APHP220918
2022-A01739-34 (Other Identifier)

Details and patient eligibility

About

Descriptive observational study in patients with spontaneous subarachnoid hemorrhage or following aneurysmal rupture to assess the presence of a post-HSA syndrome at 3 months, 6 months and 1 year, and its impact on functional outcome using the Rivermead questionnaire

Full description

Every year, subarachnoid hemorrhage affects 9.1 people per 100,000 worldwide, with a peak between the ages of 50 and 60. Its frequency and relatively young age of onset make it a major source of decline in healthy life years.

Progress over the past thirty years has led to a 57% reduction in mortality, but these figures do not always reflect the day-to-day reality of these patients, for whom recovery remains incomplete in almost half of cases. For example, a third of patients have not returned to work at one year, and of those who have, only half have returned to work full-time. In 2020, a Norwegian team showed that, at one year, a third of patients suffer from a "post-HSA syndrome", as yet little described, but which seems very similar to the post-concussion syndrome experienced by patients after head trauma. In their study, only 3% of patients with this syndrome returned to work at one year. A better understanding of the incidence of this syndrome, as well as its evolution and determinants, is therefore essential.

With this in mind, the investigators chose to assess the presence of post-SAH syndrome at 3 months and its repercussions on return to work, using the Rivermead questionnaire.

Secondly, in view of the prevalence of post-traumatic stress syndrome at 3 years (a quarter of patients), the investigators wished to study the factors determining the presence of post-HSA syndrome and an inability to return to work at 3 months, 6 months, 1 year.

Enrollment

80 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patient aged 18 to 65

  • Patient hospitalized in intensive care unit at Hôpital Lariboisière between September 2022 and September 2023 for subarachnoid hemorrhage due to aneurysmal rupture.
  • Patient affiliated to the French social security system
  • Patient expressing no objection

Exclusion criteria

  • Motor deficits persisting 1 month after SAH
  • Hospitalization > 1 month
  • Patient does not speak French
  • Patient with diagnosis of neurodegenerative disease.
  • Traumatic meningeal hemorrhage
  • Patients on AME

Trial design

80 participants in 1 patient group

patients with subarachnoid hemorrhage
Description:
Patients hospitalized in Lariboisière intensive care unit for subarachnoid hemorrhage
Treatment:
Other: questionnaire
Diagnostic Test: MoCA
Other: CIQ-R
Other: Brief-Cope
Other: mMRS
Other: SS-QoL
Diagnostic Test: BREFF
Other: PCL-5
Other: IADL
Other: SF-36

Trial contacts and locations

0

Loading...

Central trial contact

Labeyrie Marc-Antoine

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems